HIF1A and pulmonary arterial hypertension: Analyzing the serum concentrations of VEGF and HIF-1α in CTD-PAH patients and their correlations with relevant clinical indicators offers new avenues for early diagnosis, targeted and personalized treatment, and risk assessment of CTD-PAH.